Coatue Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-618,231
Closed -$92.9M 79
2022
Q4
$92.9M Buy
618,231
+196,641
+47% +$30.3M 1.04% 23
2022
Q3
$56.9M Hold
421,590
0.66% 30
2022
Q2
$62.9M Hold
421,590
0.76% 32
2022
Q1
$71.9M Sell
421,590
-636,071
-60% -$107M 0.53% 31
2021
Q4
$273M Buy
1,057,661
+23,676
+2% +$6.48M 1.21% 26
2021
Q3
$282M Sell
1,033,985
-202,332
-16% -$64.3M 1.15% 31
2021
Q2
$277M Buy
1,236,317
+894,471
+262% +$169M 1.07% 30
2021
Q1
$37.3M Buy
+341,846
New +$36.3M 0.2% 44

Other funds holding BNTX

Coatue Management's BNTX Position: Q1 2023 in Review

Coatue Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 618,231 shares — an estimated $92.9M sold.

Coatue Management first reported a position in BNTX in Q1 2021 and held it in 8 quarters. The position peaked at $282M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Coatue Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Coatue Management sold 618,231 BioNTech shares in Q1 2023, an estimated $92.9M.
  • Coatue Management first reported a position in BioNTech in Q1 2021 and held it in 8 quarters.
  • Coatue Management's BioNTech position peaked at $282M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Coatue Management's 13F filing for Q1 2023, filed 15 May 2023.